StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health total assets

Total assets on the balance sheet at the end of each period.

Elevance Health's total assets was $127.80B at Sep 30, 2026. For fiscal 2025 it was $121.49B, up 3.9% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $121.49B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$121.49B+3.9%
FY2024Dec 31, 2024$116.89B+7.3%
FY2023Dec 31, 2023$108.93B+6.0%
FY2022Dec 31, 2022$102.76B+5.4%
FY2021Dec 31, 2021$97.46B+12.5%
FY2020Dec 31, 2020$86.62B+11.8%
FY2019Dec 31, 2019$77.45B+8.2%
FY2018Dec 31, 2018$71.57B+1.5%
FY2017Dec 31, 2017$70.54B+8.4%
FY2016Dec 31, 2016$65.08B+5.5%
FY2015Dec 31, 2015$61.72B+0.1%
FY2014Dec 31, 2014$61.68B+3.5%
FY2013Dec 31, 2013$59.57B+1.1%
FY2012Dec 31, 2012$58.96B+13.0%
FY2011Dec 31, 2011$52.16B+4.0%
FY2010Dec 31, 2010$50.17B-3.8%
FY2009Dec 31, 2009$52.13B+7.7%
FY2008Dec 31, 2008$48.40B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$127.80B+4.1%
Q2 FY2026Jun 30, 2026$126.44B+3.7%
Q1 FY2026Mar 31, 2026$125.83B+5.1%
Q4 FY2025Dec 31, 2025$121.49B+3.9%
Q3 FY2025Sep 30, 2025$122.75B+5.3%
Q2 FY2025Jun 30, 2025$121.94B+7.9%
Q1 FY2025Mar 31, 2025$119.72B+7.0%
Q4 FY2024Dec 31, 2024$116.89B+7.3%
Q3 FY2024Sep 30, 2024$116.53B+5.5%
Q2 FY2024Jun 30, 2024$112.99B+3.5%
Q1 FY2024Mar 31, 2024$111.89B+2.6%
Q4 FY2023Dec 31, 2023$108.93B+6.0%
Q3 FY2023Sep 30, 2023$110.48B+7.2%
Q2 FY2023Jun 30, 2023$109.17B+8.2%
Q1 FY2023Mar 31, 2023$109.04B+8.5%
Q4 FY2022Dec 31, 2022$102.76B+5.4%
Q3 FY2022Sep 30, 2022$103.03B+5.1%
Q2 FY2022Jun 30, 2022$100.88B+5.0%
Q1 FY2022Mar 31, 2022$100.49B+5.0%
Q4 FY2021Dec 31, 2021$97.46B+12.5%
Q3 FY2021Sep 30, 2021$98.06B+13.3%
Q2 FY2021Jun 30, 2021$96.10B+9.2%
Q1 FY2021Mar 31, 2021$95.68B+16.1%
Q4 FY2020Dec 31, 2020$86.62B+11.8%
Q3 FY2020Sep 30, 2020$86.57B+11.3%
Q2 FY2020Jun 30, 2020$87.98B+16.0%
Q1 FY2020Mar 31, 2020$82.40B+10.6%
Q4 FY2019Dec 31, 2019$77.45B+8.2%
Q3 FY2019Sep 30, 2019$77.81B+4.5%
Q2 FY2019Jun 30, 2019$75.85B+2.0%
Q1 FY2019Mar 31, 2019$74.52B+1.7%
Q4 FY2018Dec 31, 2018$71.57B+1.5%
Q3 FY2018Sep 30, 2018$74.45B+9.0%
Q2 FY2018Jun 30, 2018$74.37B+9.0%
Q1 FY2018Mar 31, 2018$73.30B+6.3%
Q4 FY2017Dec 31, 2017$70.54B+8.4%
Q3 FY2017Sep 30, 2017$68.31B–
Q2 FY2017Jun 30, 2017$68.24B–
Q1 FY2017Mar 31, 2017$68.94B–
Q4 FY2016Dec 31, 2016$65.08B–

More Elevance Health figures

See a number that looks wrong?